Literature DB >> 7803639

Clinical features and duration of traveler's diarrhea in relation to its etiology.

L Mattila1.   

Abstract

Clinical features of traveler's diarrhea (TD) were studied among 126 adult Finnish tourists who developed this illness during or shortly after a visit to Morocco. Enteric pathogens were identified in 76 (60%) of cases, whereas the etiology remained unidentified in 50 cases (40%). Patients with an identified pathogen did not differ from those with TD of unknown etiology in terms of the time of onset of illness or the median frequency of unformed stools in the first 24 hours. In contrast, the median frequency of unformed stools between 24 and 48 hours (i.e., on the second day) was 1.0 among patients with no pathogen and 2.0 among those with enteric pathogens identified (P < .001). A similar difference was evident on the third day (1.0 vs. 2.5). Moreover, a lower proportion of patients with no pathogen identified had watery stools (28% vs. 55%). The durations of diarrhea and concomitant symptoms were significantly shorter and the recovery from TD was significantly quicker among the patients without an identified pathogen. Patients with one or more invasive pathogens had disease that was clearly more severe than that of patients with no pathogen identified; the difference in severity of disease was less marked for patients with invasive vs. noninvasive pathogens. Individuals with diarrhea due to Campylobacter species tended to have the most severe disease, whereas diarrhea caused by enterotoxigenic Escherichia coli seemed milder than that caused by other agents. Unfortunately, the clinician has only a limited opportunity to predict the etiology of TD and thus to assess the need for antimicrobial therapy at the onset of disease.

Entities:  

Mesh:

Year:  1994        PMID: 7803639      PMCID: PMC7109962          DOI: 10.1093/clinids/19.4.728

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Antibiotics for Travelers: What's Good and What's Not.

Authors:  Kathryn N. Suh; Jay S. Keystone
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

2.  Diarrhea in the returned traveler.

Authors:  J W Sanders; D R Tribble
Journal:  Curr Gastroenterol Rep       Date:  2001-08

3.  Multiyear prospective study of intestinal parasitism in a cohort of Peace Corps volunteers in Guatemala.

Authors:  B L Herwaldt; K R de Arroyave; S P Wahlquist; A M de Merida; A S Lopez; D D Juranek
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 4.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Travelers' diarrhea: modern concepts and new developments.

Authors:  Andrew W DuPont; Herbert L DuPont
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

6.  Diarrheagenic Escherichia coli and acute and persistent diarrhea in returned travelers.

Authors:  C Schultsz; J van den Ende; F Cobelens; T Vervoort; A van Gompel; J C Wetsteyn; J Dankert
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Travellers' diarrhea in children.

Authors:  Pierre J Plourde
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

8.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

9.  Frequency and distribution of diarrhoeagenic Escherichia coli strains isolated from pediatric patients with diarrhoea in Bosnia and Herzegovina.

Authors:  Amela Dedeić-Ljubović; Mirsada Hukić; Daria Bekić; Amra Zvizdić
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

Review 10.  Travellers' diarrhoea: contemporary approaches to therapy and prevention.

Authors:  Herbert L DuPont
Journal:  Drugs       Date:  2006       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.